IRVINE, Calif.--(BUSINESS WIRE)--eGene Inc. (OTCBB:EGEI), a leading biotechnology company and developer of a compact and automated digital genetic analyzer, announced today that the Company has received notification that the European Patent Office has allowed its patent application “OPTICAL DETECTION IN A MULTI-CHANNEL BIO-SEPARATION SYSTEM.” This marks the Company's 11th patent worldwide.
